Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid LeukemiaClaude Preudhomme, François Guilhot, Valérie Coiteux et al.|New England Journal of Medicine|2010Cited by 385
Disease characteristics and monitoring of IDH1/IDH2-mutated acute myeloid leukemiaM. Dantec, Laurène Fenwarth, Maxime Dufossé et al.|Blood Cancer Journal|2025Cited by 4
Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies: Insights from a large-scale NGS-based screening studyLeïla Ben Dhia, Nicolas Duployez, Mathieu Wémeau et al.|Blood|2025Cited by 0